
William P. Neuder
Examiner (ID: 10341)
| Most Active Art Unit | 3672 |
| Art Unit(s) | 3672, 2899, 3625, 3642, 3506 |
| Total Applications | 4583 |
| Issued Applications | 4090 |
| Pending Applications | 166 |
| Abandoned Applications | 332 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19379203
[patent_doc_number] => 20240269073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => CO-AMORPHOUS FORMS FOR USE IN CANCER THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/564552
[patent_app_country] => US
[patent_app_date] => 2022-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12674
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18564552
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/564552 | CO-AMORPHOUS FORMS FOR USE IN CANCER THERAPY | Jun 6, 2022 | Pending |
Array
(
[id] => 19387736
[patent_doc_number] => 20240277606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => METHODS FOR THE PULSED DELIVERY OF BIOACTIVE AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/567140
[patent_app_country] => US
[patent_app_date] => 2022-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8987
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18567140
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/567140 | METHODS FOR THE PULSED DELIVERY OF BIOACTIVE AGENTS | Jun 6, 2022 | Pending |
Array
(
[id] => 19343561
[patent_doc_number] => 20240252524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => Process to Reduce Ivermectin Particle Size
[patent_app_type] => utility
[patent_app_number] => 18/565724
[patent_app_country] => US
[patent_app_date] => 2022-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5397
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18565724
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/565724 | Process to Reduce Ivermectin Particle Size | May 30, 2022 | Pending |
Array
(
[id] => 19417306
[patent_doc_number] => 20240293429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => MICROBIAL-TRIGGERED ORAL INTESTINAL DRUG DELIVERY FORMULATION AND METHOD OF PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/575988
[patent_app_country] => US
[patent_app_date] => 2022-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6231
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18575988
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/575988 | MICROBIAL-TRIGGERED ORAL INTESTINAL DRUG DELIVERY FORMULATION AND METHOD OF PREPARATION THEREOF | May 29, 2022 | Pending |
Array
(
[id] => 17960265
[patent_doc_number] => 20220340845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => CLEANING COMPOSITION, METHOD OF MAKING AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/804312
[patent_app_country] => US
[patent_app_date] => 2022-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11319
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17804312
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/804312 | Cleaning composition, method of making and use thereof | May 26, 2022 | Issued |
Array
(
[id] => 19316658
[patent_doc_number] => 20240238198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => AN ADVENTITIAL PAINTING MODALITY OF LOCAL DRUG DELIVERY TO ABATE INTIMAL HYPERPLASIA
[patent_app_type] => utility
[patent_app_number] => 18/562898
[patent_app_country] => US
[patent_app_date] => 2022-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14476
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18562898
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/562898 | AN ADVENTITIAL PAINTING MODALITY OF LOCAL DRUG DELIVERY TO ABATE INTIMAL HYPERPLASIA | May 19, 2022 | Pending |
Array
(
[id] => 19584987
[patent_doc_number] => 20240382544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-21
[patent_title] => COMPOSITION FOR ANTI-OBESITY AND PREVENTING OR TREATING MUSCLE LOSS, CONTAINING CATECHIN GLYCOSIDE EXTRACT DERIVED FROM PLANT IN GENUS ULMUS AS ACTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 18/266174
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6662
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18266174
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/266174 | COMPOSITION FOR ANTI-OBESITY AND PREVENTING OR TREATING MUSCLE LOSS, CONTAINING CATECHIN GLYCOSIDE EXTRACT DERIVED FROM PLANT IN GENUS ULMUS AS ACTIVE INGREDIENT | May 9, 2022 | Pending |
Array
(
[id] => 18064415
[patent_doc_number] => 20220395502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING AZD9291
[patent_app_type] => utility
[patent_app_number] => 17/729162
[patent_app_country] => US
[patent_app_date] => 2022-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12707
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17729162
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/729162 | PHARMACEUTICAL COMPOSITIONS COMPRISING AZD9291 | Apr 25, 2022 | Abandoned |
Array
(
[id] => 18064388
[patent_doc_number] => 20220395475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => AFRAMOMUM MELEGUETA COMPOSITION AND METHOD FOR HEALTH MAINTENANCE
[patent_app_type] => utility
[patent_app_number] => 17/726519
[patent_app_country] => US
[patent_app_date] => 2022-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9179
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17726519
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/726519 | AFRAMOMUM MELEGUETA COMPOSITION AND METHOD FOR HEALTH MAINTENANCE | Apr 20, 2022 | Pending |
Array
(
[id] => 17958531
[patent_doc_number] => 20220339111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => IMMEDIATE-RELEASE TABLETS CONTAINING A DRUG AND PROCESSES FOR FORMING THE TABLETS
[patent_app_type] => utility
[patent_app_number] => 17/722158
[patent_app_country] => US
[patent_app_date] => 2022-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24133
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17722158
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/722158 | IMMEDIATE-RELEASE TABLETS CONTAINING A DRUG AND PROCESSES FOR FORMING THE TABLETS | Apr 14, 2022 | Pending |
Array
(
[id] => 19232050
[patent_doc_number] => 20240189241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => PHOSPHOLIPIDS AS ANION CHELATING AGENTS IN PHARMACEUTICAL FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 18/284916
[patent_app_country] => US
[patent_app_date] => 2022-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11039
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18284916
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/284916 | PHOSPHOLIPIDS AS ANION CHELATING AGENTS IN PHARMACEUTICAL FORMULATIONS | Mar 30, 2022 | Pending |
Array
(
[id] => 19246769
[patent_doc_number] => 20240197753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => PHARMACEUTICAL COMPOSITION FOR IMPROVING CARDIAC FUNCTION
[patent_app_type] => utility
[patent_app_number] => 18/283585
[patent_app_country] => US
[patent_app_date] => 2022-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25712
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18283585
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/283585 | PHARMACEUTICAL COMPOSITION FOR IMPROVING CARDIAC FUNCTION | Mar 24, 2022 | Pending |
Array
(
[id] => 19155952
[patent_doc_number] => 20240148658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => ADHESIVE MICROCAPSULES FOR MECHANICALLY-RESPONSIVE THERAPEUTIC DELIVERY
[patent_app_type] => utility
[patent_app_number] => 18/552711
[patent_app_country] => US
[patent_app_date] => 2022-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6887
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18552711
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/552711 | ADHESIVE MICROCAPSULES FOR MECHANICALLY-RESPONSIVE THERAPEUTIC DELIVERY | Mar 23, 2022 | Pending |
Array
(
[id] => 19232049
[patent_doc_number] => 20240189240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING ZOLMITRIPTAN
[patent_app_type] => utility
[patent_app_number] => 18/552420
[patent_app_country] => US
[patent_app_date] => 2022-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -54
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18552420
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/552420 | PHARMACEUTICAL COMPOSITIONS COMPRISING ZOLMITRIPTAN | Mar 23, 2022 | Pending |
Array
(
[id] => 19232242
[patent_doc_number] => 20240189433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => SUPERABSORBENT HYDROGELS
[patent_app_type] => utility
[patent_app_number] => 18/551592
[patent_app_country] => US
[patent_app_date] => 2022-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17059
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18551592
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/551592 | SUPERABSORBENT HYDROGELS | Mar 22, 2022 | Pending |
Array
(
[id] => 19960387
[patent_doc_number] => 12329859
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-17
[patent_title] => Bioerodible drug delivery devices
[patent_app_type] => utility
[patent_app_number] => 17/697084
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 4706
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17697084
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/697084 | Bioerodible drug delivery devices | Mar 16, 2022 | Issued |
Array
(
[id] => 19170762
[patent_doc_number] => 20240156736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => LACOSAMIDE PHARMACEUTICAL COMPOSITION PREPARATION METHOD AND APPLICATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/551068
[patent_app_country] => US
[patent_app_date] => 2022-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8591
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18551068
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/551068 | LACOSAMIDE PHARMACEUTICAL COMPOSITION PREPARATION METHOD AND APPLICATIONS THEREOF | Mar 15, 2022 | Pending |
Array
(
[id] => 17684901
[patent_doc_number] => 20220192193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => Compositions and Methods for Attracting Mosquitoes and Repelling Sand Flies
[patent_app_type] => utility
[patent_app_number] => 17/691552
[patent_app_country] => US
[patent_app_date] => 2022-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8363
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17691552
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/691552 | Compositions and Methods for Attracting Mosquitoes and Repelling Sand Flies | Mar 9, 2022 | Abandoned |
Array
(
[id] => 17865240
[patent_doc_number] => 20220287975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => MODIFIED RELEASE COMPOSITIONS OF NAFAMOSTAT AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/689255
[patent_app_country] => US
[patent_app_date] => 2022-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17689255
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/689255 | MODIFIED RELEASE COMPOSITIONS OF NAFAMOSTAT AND METHODS OF USING SAME | Mar 7, 2022 | Pending |
Array
(
[id] => 17775011
[patent_doc_number] => 20220241360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => ORALLY DISINTEGRATING, SUBLINGUAL AND BUCCAL FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/687373
[patent_app_country] => US
[patent_app_date] => 2022-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3706
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17687373
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/687373 | ORALLY DISINTEGRATING, SUBLINGUAL AND BUCCAL FORMULATIONS | Mar 3, 2022 | Abandoned |